Summarized by Masters of Longevity from PR Newswire.
TRANSFORM-II found similar one-year target-lesion failure rates between SCB and EES.
Key Takeaways
- A sirolimus-coated balloon was noninferior to EES.
- Careful lesion preparation was required for successful outcomes.
- Findings are from a randomized but not long-term study.
